Duloxetine Active Pharmaceutical Ingredients Market

Active pharmaceutical ingredients (APIs) are used in the manufacturing of pharmaceutical formulations. Duloxetine is a serotonin-norepinephrine reuptake inhibitor used in the treatment of depression and anxiety. Moreover, it is used to help relieve neuropathic pain in people with diabetes or ongoing pain due to medical conditions such as arthritis, chronic back pain, or fibromyalgia.
Duloxetine Active Pharmaceutical Ingredients Market contains market size and forecasts of Duloxetine Active Pharmaceutical Ingredients (API) in global, including the following market information:
Global Duloxetine Active Pharmaceutical Ingredients (API) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Duloxetine Active Pharmaceutical Ingredients (API) Market Sales, 2017-2022, 2023-2028, (MT)
Global top five Duloxetine Active Pharmaceutical Ingredients (API) companies in 2021 (%)
The global Duloxetine Active Pharmaceutical Ingredients (API) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Major Depression Drug Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Duloxetine Active Pharmaceutical Ingredients (API) include Teva Pharmaceutical Industries Ltd (Israel), Sun Pharmaceutical Industries Ltd (India), Aurobindo Pharma (India), Lupin (India), Zydus Cadila (India), Eli Lilly and Company (United States), Shodhana Laboratories (India), Hetero (India) and Apotex (Canada), etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Duloxetine Active Pharmaceutical Ingredients (API) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Duloxetine Active Pharmaceutical Ingredients (API) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Duloxetine Active Pharmaceutical Ingredients (API) Market Segment Percentages, by Type, 2021 (%)
Major Depression Drug
Generalized Anxiety Disorder Drug
Fibromyalgia Drugs
Neuropathic Pain Medication
Other
Global Duloxetine Active Pharmaceutical Ingredients (API) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Duloxetine Active Pharmaceutical Ingredients (API) Market Segment Percentages, by Application, 2021 (%)
Pharmaceutical and Biotechnology Industries
Hospital
Other
Global Duloxetine Active Pharmaceutical Ingredients (API) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Duloxetine Active Pharmaceutical Ingredients (API) Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Duloxetine Active Pharmaceutical Ingredients (API) revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Duloxetine Active Pharmaceutical Ingredients (API) revenues share in global market, 2021 (%)
Key companies Duloxetine Active Pharmaceutical Ingredients (API) sales in global market, 2017-2022 (Estimated), (MT)
Key companies Duloxetine Active Pharmaceutical Ingredients (API) sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Teva Pharmaceutical Industries Ltd (Israel)
Sun Pharmaceutical Industries Ltd (India)
Aurobindo Pharma (India)
Lupin (India)
Zydus Cadila (India)
Eli Lilly and Company (United States)
Shodhana Laboratories (India)
Hetero (India)
Apotex (Canada)
Shionogi (US)
Zhejiang Huahai Pharmaceutical (China)